Literature DB >> 28454675

Maximising the impact of inactivated polio vaccines.

Elizabeth B Brickley1, Peter F Wright2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28454675      PMCID： PMC6047357          DOI： 10.1016/S1473-3099(17)30236-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  12 in total

1.  Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.

Authors:  Miguel O'Ryan; Ananda S Bandyopadhyay; Rodolfo Villena; Mónica Espinoza; José Novoa; William C Weldon; M Steven Oberste; Steve Self; Bhavesh R Borate; Edwin J Asturias; Ralf Clemens; Walter Orenstein; José Jimeno; Ricardo Rüttimann; Sue Ann Costa Clemens
Journal:  Lancet Infect Dis       Date:  2015-08-26       Impact factor: 25.071

2.  Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba.

Authors:  Sonia Resik; Alina Tejeda; Pedro Mas Lago; Manuel Diaz; Ania Carmenates; Luis Sarmiento; Nilda Alemañi; Belkis Galindo; Anthony Burton; Martin Friede; Mauricio Landaverde; Roland W Sutter
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

3.  Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign - Telangana State, India, June 2016.

Authors:  Sunil Bahl; Harish Verma; Pankaj Bhatnagar; Pradeep Haldar; Asish Satapathy; K N Arun Kumar; Jennifer Horton; Concepcion F Estivariz; Abhijeet Anand; Roland Sutter
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-26       Impact factor: 17.586

Review 4.  Poliovirus vaccination options for achieving eradication and securing the endgame.

Authors:  Concepción F Estívariz; Mark A Pallansch; Abhijeet Anand; Steven G F Wassilak; Roland W Sutter; Jay D Wenger; Walter A Orenstein
Journal:  Curr Opin Virol       Date:  2013-06-10       Impact factor: 7.090

5.  Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.

Authors:  Edwin J Asturias; Ananda S Bandyopadhyay; Steve Self; Luis Rivera; Xavier Saez-Llorens; Eduardo Lopez; Mario Melgar; James T Gaensbauer; William C Weldon; M Steven Oberste; Bhavesh R Borate; Chris Gast; Ralf Clemens; Walter Orenstein; Miguel O'Ryan G; José Jimeno; Sue Ann Costa Clemens; Joel Ward; Ricardo Rüttimann
Journal:  Lancet       Date:  2016-05-19       Impact factor: 79.321

6.  Polio eradication. Efficacy of inactivated poliovirus vaccine in India.

Authors:  Hamid Jafari; Jagadish M Deshpande; Roland W Sutter; Sunil Bahl; Harish Verma; Mohammad Ahmad; Abhishek Kunwar; Rakesh Vishwakarma; Ashutosh Agarwal; Shilpi Jain; Concepcion Estivariz; Raman Sethi; Natalie A Molodecky; Nicholas C Grassly; Mark A Pallansch; Arani Chatterjee; R Bruce Aylward
Journal:  Science       Date:  2014-08-22       Impact factor: 47.728

7.  Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial.

Authors:  Xavier Sáez-Llorens; Ralf Clemens; Geert Leroux-Roels; José Jimeno; Sue Ann Costa Clemens; William C Weldon; M Steven Oberste; Natanael Molina; Ananda S Bandyopadhyay
Journal:  Lancet Infect Dis       Date:  2015-12-21       Impact factor: 71.421

8.  Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.

Authors:  Peter F Wright; Ruth I Connor; Wendy F Wieland-Alter; Anne G Hoen; Austin W Boesch; Margaret E Ackerman; M Steven Oberste; Chris Gast; Elizabeth B Brickley; Edwin J Asturias; Ricardo Rüttimann; Ananda S Bandyopadhyay
Journal:  Lancet Infect Dis       Date:  2016-09-13       Impact factor: 25.071

9.  Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial.

Authors:  Luis Rivera; Rasmus S Pedersen; Lourdes Peña; Klaus J Olsen; Lars V Andreasen; Ingrid Kromann; Pernille I Nielsen; Charlotte Sørensen; Jes Dietrich; Ananda S Bandyopadhyay; Birgit Thierry-Carstensen
Journal:  Lancet Infect Dis       Date:  2017-04-25       Impact factor: 25.071

10.  Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial.

Authors:  Jacob John; Sidhartha Giri; Arun S Karthikeyan; Miren Iturriza-Gomara; Jayaprakash Muliyil; Asha Abraham; Nicholas C Grassly; Gagandeep Kang
Journal:  Lancet       Date:  2014-07-10       Impact factor: 79.321
View more
  2 in total

1.  Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine-only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants.

Authors:  Elizabeth B Brickley; Wendy Wieland-Alter; Ruth I Connor; Margaret E Ackerman; Austin W Boesch; Minetaro Arita; William C Weldon; Miguel G O'Ryan; Ananda S Bandyopadhyay; Peter F Wright
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

2.  Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden.

Authors:  Elizabeth B Brickley; Ruth I Connor; Wendy F Wieland-Alter; Marc S Collett; Marianne Hartford; Harrie Van Der Avoort; Austin W Boesch; Joshua A Weiner; Margaret E Ackerman; Mark A McKinlay; Minetaro Arita; Ananda S Bandyopadhyay; John F Modlin; Peter F Wright
Journal:  BMJ Glob Health       Date:  2019-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.